BioCentury
ARTICLE | Financial News

MD Anderson launches neuroscience newco with $31M series A

August 17, 2018 5:25 PM UTC

The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners (Seattle, Wash.) have co-founded Magnolia Neurosciences Corp. (New York, N.Y.), which launched Aug. 13 with a $31 million series A round.

Eli Lilly and Co. (NYSE:LLY) and Pfizer Ventures co-led the A round, with participation from AbbVie Ventures, Alexandria Venture Investments, Arch Venture Partners, Innovate NY Fund, J&J Innovation-JJDC Inc., Partnership Fund for New York City, Watson Fund, the corporate venture fund of WuXi AppTec Co. Ltd. (Shanghai:603259) and 180 Degree Capital...